🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David P. Nicolau

NKT Therapeutics (United States)

ORCID: 0000-0002-4148-0165

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “In vivopharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria”.

In vivopharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria

Journal of Antimicrobial Chemotherapy(2020)10.1093/jac/dkaa373

N/A

0DataRank · unranked

47 citations

Safa S. Almarzoky Abuhussain, David P. Nicolau, Kamilia Abdelraouf

Establishment of a diverse pheno-genotypic challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa suitable for use in the murine pneumonia model

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae388

N/A

0DataRank · unranked

6 citations

Alissa M Padgett, Erin M Duffy, David P. Nicolau, Andrew J Fratoni

Quantitative performance of humanized serum and epithelial lining fluid exposures of tigecycline and levofloxacin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae333

N/A

0DataRank · unranked

3 citations

Alissa M Padgett, Erin M Duffy, David P. Nicolau, Andrew J Fratoni

Development and confirmation of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin in a standardized neutropenic murine pneumonia model

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae432

N/A

0DataRank · unranked

3 citations

Alissa M Padgett, Hanna Roenfanz, Erin M Duffy, David P. Nicolau, Andrew J Fratoni

Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model

Journal of Antimicrobial Chemotherapy(2025)10.1093/jac/dkaf100

N/A

0DataRank · unranked

2 citations

Alissa M Padgett, Erin M Duffy, David P. Nicolau, Andrew J Fratoni